# Vertex Pharmaceuticals

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/vertex-pharmaceuticals/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | American pharmaceutical company |
| OpenAlex ID | https://openalex.org/F4320312517 |
| ROR ID | https://ror.org/00anb1726 |
| Works | 1,771 |

## Funder papers

- [KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary](https://scholariq.org/papers/kdigo-2025-clinical-practice-guideline-for-the-evaluation-management-and/)
- [What do clinical trials teach us about the pathophysiology of human IgA nephropathy?](https://scholariq.org/papers/what-do-clinical-trials-teach-us-about-the-pathophysiology-of-human-iga/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
